VESICARE 5MG 30TAB

VESICARE 5MG 30TAB

164.00 

*recommended price

Find out how to buy and cost VESICARE 5MG 30TAB in Europe you can make a request on the site.
We will help in the preparation of customs documents and accompanying documentation for delivery VESICARE 5MG 30TAB , get permission from airport security.

Foreign citizens who purchase drugs while in Israel can receive a refund of VAT (TAX FREE) upon departure at the airport

Manufacturer: CTS
Amount in a package: 30
Manufacturer’s website link
Description: VESICARE 5MG 30TAB is a medication that belongs to the category of urological agents. It contains the active ingredient solifenacin, which is an antagonist of muscarinic receptors. This medication is used to treat symptoms of overactive bladder and urinary incontinence in patients diagnosed with neurogenic bladder. It helps reduce the frequency of urination, decrease the need to use the bathroom at night, and improve control over urination. VESICARE 5MG 30TAB is an effective and safe treatment for urological problems and may be prescribed by a doctor to achieve optimal treatment results. However, it is important to consult with a doctor and read the instructions for use before starting to take the medication.
VESICARE is a highly effective medication for treating overactive bladder symptoms. However, purchasing it through traditional means can be time-consuming and inconvenient. That’s why buying VESICARE online is the better option. Not only does it save you the hassle of going to a physical store, but it also offers the convenience of doorstep delivery. Additionally, online purchases often come with discounts and promotions, making it a more cost-effective choice. With just a few clicks, you can have VESICARE delivered to your doorstep, ensuring a hassle-free and efficient shopping experience. So why wait? Buy VESICARE online today and experience the convenience and savings for yourself.

Reviews

There are no reviews yet.

Be the first to review “VESICARE 5MG 30TAB”

Your email address will not be published.